{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:46:18Z","timestamp":1760132778957,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":2052,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jpainsymman.2013.12.248","type":"journal-article","created":{"date-parts":[[2014,4,18]],"date-time":"2014-04-18T12:43:26Z","timestamp":1397825006000},"page":"e7-e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Erlotinib or Gefitinib as First-Choice Therapy for Bronchorrhea in Bronchioloalveolar Carcinoma"],"prefix":"10.1016","volume":"47","author":[{"given":"\u00c1lvaro","family":"Sanz Rubiales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"de la Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 \u00c1ngel","family":"Berezo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2013.12.248_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1349-7006.2003.tb01464.x","article-title":"A\u00a0report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (\u201cIressa\u201d)","volume":"94","author":"Yano","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jpainsymman.2013.12.248_bib2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/JTO.0b013e3181461999","article-title":"Erlotinib effective against refractory bronchorrhea from advanced non-small cell lung cancer","volume":"2","author":"Thotathil","year":"2007","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jpainsymman.2013.12.248_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1378\/chest.110.1.281","article-title":"Bronchioloalveolar carcinoma accompanied by severe bronchorrhea","volume":"110","author":"Hidaka","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.jpainsymman.2013.12.248_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-7819-1-8","article-title":"Successful treatment of persistent bronchorrhea by gefitinib in a case with recurrent bronchioloalveolar carcinoma: a case report","volume":"1","author":"Takao","year":"2003","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.jpainsymman.2013.12.248_bib5","first-page":"70","article-title":"Prompt control of bronchorrhea in patients with bronchioloalveolar carcinoma treated with gefitinib (Iressa)","volume":"13","author":"Milton","year":"2005","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2013.12.248_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lungcan.2004.11.027","article-title":"Novel effects of gefitinib on mucin production in bronchioloalveolar carcinoma; two case reports","volume":"49","author":"Kitazaki","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jpainsymman.2013.12.248_bib7","first-page":"224","article-title":"EGFR tyrosine kinase inhibitors as a targeted therapy for bronchioloalveolar carcinoma of the lung: a case report of a clinically prompt and intensive response and literature review","volume":"23","author":"Svoboda","year":"2010","journal-title":"Klin Onkol"},{"key":"10.1016\/j.jpainsymman.2013.12.248_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1378\/chest.11-0956","article-title":"Severe bronchorrhea in a patient with bronchioloalveolar carcinoma","volume":"141","author":"Popat","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jpainsymman.2013.12.248_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1378\/chest.128.1.317","article-title":"Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer","volume":"118","author":"Hsieh","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jpainsymman.2013.12.248_bib10","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1158\/1078-0432.CCR-11-1468","article-title":"Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design","volume":"17","author":"Chaft","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392414001912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392414001912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:11:20Z","timestamp":1760130680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392414001912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0885392414001912"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.12.248","relation":{},"ISSN":["0885-3924"],"issn-type":[{"type":"print","value":"0885-3924"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erlotinib or Gefitinib as First-Choice Therapy for Bronchorrhea in Bronchioloalveolar Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.12.248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}